Ola Brodin

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: NUTRIENTS. 2015;7(6):4978-4994
Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study
Brodin O; Eksborg S; Wallenberg M; Asker-Hagelberg C; Larsen EH; Mohlkert D; Lenneby-Helleday C; Jacobsson H; Linder S; Misra S; Bjornstedt M
Article: BRITISH JOURNAL OF RADIOLOGY. 2013;86(1025):20130015
Predictive value of modelled tumour control probability based on individual measurements of in vitro radiosensitivity and potential doubling time
Hedman M; Bjork-Eriksson T; Brodin O; Toma-Dasu I
Article: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2012;16(7):1593-1605
Effects of redox modulation by inhibition of thioredoxin reductase on radiosensitivity and gene expression
Selenius M; Hedman M; Brodin D; Gandin V; Rigobello MP; Flygare J; Marzano C; Bindoli A; Brodin O; Bjornstedt M; Fernandes AP
Article: ANTICANCER RESEARCH. 2012;32(4):1339-1346
The Value of Induction Chemotherapy for Survival in Patients with Non-small Cell Lung Cancer Treated with Radiotherapy
Holgersson G; Sandelin M; Hoye E; Bergstrom S; Henriksson R; Ekman S; Nyman J; Helsing M; Friesland S; Brodin O; Holgersson M; Lundstrom KL; Janson C; Ekberg L; Morth C; Blystad T; Ewers S-B; Loden B; Bergqvist M
Article: ANTICANCER RESEARCH. 2011;31(4):1125-1130
Fractionated Irradiation of Five Human Lung Cancer Cell Lines and Prediction of Survival According to a Radiobiology Model
Hedman M; Bergqvist M; Brattstrom D; Brodin O
Article: LUNG CANCER. 2011;71(2):166-172
Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: Satellite-A phase II study from the Swedish Lung Cancer Study Group
Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Loden B; Ewers S-B; Bergstrom S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J
Article: HISTOPATHOLOGY. 2009;55(3):313-320
Expression profiles of thioredoxin family proteins in human lung cancer tissue: correlation with proliferation and differentiation
Fernandes AP; Capitanio A; Selenius M; Brodin O; Rundlof A-K; Bjornstedt M
Article: ACTA ONCOLOGICA. 2009;48(4):584-590
Comparison of predicted and clinical response to radiotherapy: A radiobiology modelling study
Hedman M; Bjork-Eriksson T; Mercke C; West C; Hesselius P; Brodin O
Article: BIOCHEMICAL PHARMACOLOGY. 2008;75(11):2092-2099
Treatment of lung cancer cells with cytotoxic levels of sodium selenite:: Effects on the thioredoxin system
Selenius M; Fernandes AP; Brodin O; Bjornstedt M; Rundlof A-K
Article: NEOPLASMA. 2006;53(4):285-290
Role of circulating cytokeratin fragments and angiogenic factors in NSCLC patients stage IIIa-IIIb receiving curatively intended treatment.
Eriksson P; Brattström D; Hesselius P; Larsson A; Bergström S; Ekman S; Goike H; Wagenius G; Brodin O; Bergqvist M
Article: BMC CANCER. 2004;4:66
The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival.
Bergqvist M; Brattström D; Larsson A; Hesselius P; Brodin O; Wagenius G
Article: MEDICAL SCIENCE MONITOR. 2004;10(9):BR331-BR338
Endothelial markers and circulating angiogenic factors and p53 may be potential markers for recurrence in surgically resected non-small cell lung cancer patients.
Brattström D; Bergqvist M; Wester K; Hesselius P; Ren Z-P; Scheibenpflug L; Wagenius G; Brodin O
Article: ACTA ONCOLOGICA. 2004;43(1):80-86
HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer.
Brattström D; Wester K; Bergqvist M; Hesselius P; Malmström P-U; Nordgren H; Wagenius G; Brodin O
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2004;350(4):351-360
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
Le Chevalier T; Arriagada R; Le Péchoux C; Grunenwald D; Dunant A; Pignon JP; Tarayre M; Abratt R; Arriagada R; Bergman B; Gralla R; Grunenwald D; Le Chevalier T; Orlowski T; Papadakis E; Pinel MIS; Araujo C; Della Torre H; de Solchaga MM; Abdi E; Blum R; Ball D; Basser R; De Boer R; Bishop J; Brigham B; Davis S; Fox D; Richardson G; Wyld D; Pirker R; Humblet Y; Delaunois L; Van Meerbeeck JP; Germonpre P; Vansteenkiste J; Nackaerts K; Pinel MIS; Vauthier G; Younes RN; Arriagada R; Baeza R; Carvajal P; Kleinman S; Orlandi L; Castro C; Godoy J; Kosatova K; Gaafar R; Azarian R; Benichou M; Boudoux L; Boyer G; Chirat E; Chomy F; Coëtmeur D; Couderc LJ; Coudert B; Crequit J; David P; Delaval P; Dohollou N; Foucher P; Gonzalez G; Jeanfaivre T; Joveniaux A; Kanoui AA; Le Chevalier T; Le Péchoux C; Baldeyrou P; Debrosse D; Girard P; Grunenwald D; Ruffié P; Leclerc P; Milleron B; Monnet I; Monnot H; Morere JF; Naman H; Dides S; Noel JP; Otto J; Ozanne F; Ozenne G; Parent F; Peureux M; Picon B; Pujol JL; Quoix E; Rabut H; Rivière A; Gervais R; Icard P; Rixe O; Deplanque G; Sevin D; Spaeth D; Tourani JM; Toussaint C; Tuchais C; Vannetzel JM; VArflet F; Virally J; Zaegel M; Zalcman G; Livatorwski A; Eberhardt W; Alexopoulos C; Apostolopoulou F; Bachlitzanakis N; Bellenis I; Christaki P; Dosios T; Georgoulias V; Iliadis K; Kardamakis D; Konstantinou M; Kotsovoulou V; Pouliou M; Michalopoulou P; Papadakis E; Agelidou A; Zarogoulidis K; Gottfried M; Kovner F; Agostara B; Ascoli M; Brigandi A; Cigolari S; Colucci G; De Braud F; Dirosa T; Giglio A; Maiorino A; Masotti A; Rusca M; Ogawara M; Osada H; Park K; Jackevicius A; Smickoska S; El Gueddari BE; Aaesebo U; Desales R; Furman M; Kozlowski M; Laudansk J; Grodzki T; Orlowski T; Chabowski M; Pluzanska A; Gaspar L; Ciuleanu T; Baumohl J; Cerna M; Bitenc M; Abratt R; Chasen M; Alberola V; Azagra P; Garcia PB; CArdenal F; Curto CP; Salinas J; Serrate RS; Bergman B; Andersson L; Hero U; Mansson T; Martinsson JE; Hillerdal G; Agrenius V; Sederholm C; Arvidsson I; Ydreborg SO; Thaning L; Sjögren A; Jönsson P; Grip H; Singer J; Lundgren R; Brodin O; Andejani D; Branden E; Lamberg K; Riska H; Egli E; Joss R; Martinelli G; Roth A; Stahel R; Stupp R; El Kamel A; Gralla R; Cole JT; Jahanzeb M; Wiznitzer I; Masters GA; Radosavljevic G; Babiker A; Green M; Osterlind K; Taube A; Wedel H
Article: LUNG CANCER. 2004;43(1):55-62
Serum VEGF and bFGF adds prognostic information in patients with normal platelet counts when sampled before, during and after treatment for locally advanced non-small cell lung cancer.
Brattström D; Bergqvist M; Hesselius P; Larsson A; Wagenius G; Brodin O
Article: ANTICANCER RESEARCH. 2003;23(2B):1207-1212
p53 status and its in vitro relationship to radiosensitivity and chemosensitivity in lung cancer.
Bergqvist M; Brattström D; Gullbo J; Hesselius P; Brodin O; Wagenius G
Article: ANTICANCER RESEARCH. 2003;23(1B):531-536
Tissue polypeptide antigen (TPA), hyaluronan and CA 125 as serum markers in malignant mesothelioma.
Hedman M; Arnberg H; Wernlund J; Riska H; Brodin O
Article: LUNG CANCER. 2002;37(1):57-63
Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients.
Brattström D; Bergqvist M; Hesselius P; Larsson A; Lamberg K; Wernlund J; Brodin O; Wagenius G
Article: ANTICANCER RESEARCH. 2002;22(2B):1239-1242
Radiation treatment of T1-T4 squamous cell carcinoma of the larynx: a retrospective analysis and long-term follow-up of 135 patients.
Bergqvist M; Brodin O; Pouzon A; Linder A; Hesselius P; Blomquist E
Article: MEDICAL ONCOLOGY. 2002;19(3):151-159
Selection of chemotherapy by ex vivo assessment of tumor sensitivity to cytotoxic drugs
Berglund Å; Glimelius B; Bergh J; Brodin O; Fjällskog ML; Hagberg H; von Heideman A; Larsson R; Tholander B; de la Torre M; Åström G; Öberg K; Parö G; Nygren P
Article: ANTICANCER RESEARCH. 2001;21(6A):4141-4145
Serum p53 autoantibodies as prognostic marker in patients with oesophageal carcinoma.
Bergqvist AS; Bergqvist M; Brattstrom D; Hesselius P; Larsson A; Brodin O; Wagenius G
Article: ANTICANCER RESEARCH. 2001;21(6A):3925-3928
Radiation responsiveness of human lung cancer cell lines measured with a short term semiautomatic assay.
Xing T; Brattstrom D; Bergqvist M; Isaksson U; Wagenius G; Brodin O
Article: ANTICANCER RESEARCH. 2001;21(6A):3853-3856
The frequency of micronuclei in lung cancer cell lines and their correlation to intrinsic radiation sensitivity.
Bergqvist AS; Brattström D; Bergqvist M; Brodin O; Wagenius G; Zetterberg LA
Article: ACTA ONCOLOGICA. 2001;40(5):566-573
A Swedish study of chemoradiation in squamous cell carcinoma of the esophagus
Stockeld D; Tennvall J; Wagenius G; Albertsson M; Backman L; Brodin O; Cwikiel M; Granström L; Gustafsson G; Gustavsson S; Hambraeus G; Lewensohn R; Sjöstedt S; Strander H; Åberg B; Fagerberg J
Article: PATIENT EDUCATION AND COUNSELING. 2000;40(3):219-229
Group rehabilitation for cancer patients:: satisfaction and perceived benefits
Petersson LM; Berglund G; Brodin O; Glimelius B; Sjödén PO
Article: ANTICANCER RESEARCH. 2000;20(3B):2087-2090
Different fraction schedules and combinations with chemotherapy in radiation treatment of non-small cell lung cancer.
Brattström D; Bergqvist M; Hesselius P; Wagenius G; Brodin O
Article: ANTICANCER RESEARCH. 2000;20(3A):1375-1380
In vitro PET evaluations in lung cancer cell lines.
Xing T; Wu F; Brodin O; Fasth KJ; Långström B; Bergström M
Visa fler

Artiklar

Nyheter från KI

Kalenderhändelser från KI